Please login to the form below

Not currently logged in
Email:
Password:

Braeburn Pharmaceuticals

This page shows the latest Braeburn Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....